Route One Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141M Buy
280,400
+21,700
+8% +$10.4M 5.65% 9
2026
Q1
$127M Sell
258,700
-4,900
-2% -$2.66M 5.41% 8
2025
Q4
$153M Sell
263,600
-29,780
-10% -$16.8M 5.67% 9
2025
Q3
$142M Hold
293,380
5.27% 9
2025
Q2
$119M Buy
293,380
+60,950
+26% +$25.5M 5.21% 8
2025
Q1
$116M Hold
232,430
4.82% 8
2024
Q4
$121M Buy
232,430
+21,550
+10% +$11.8M 4.72% 9
2024
Q3
$130M Hold
210,880
4.57% 9
2024
Q2
$117M Hold
210,880
4.04% 10
2024
Q1
$123M Hold
210,880
4.47% 10
2023
Q4
$112M Buy
210,880
+65,550
+45% +$31.7M 2.27% 14
2023
Q3
$73.6M Buy
+145,330
New +$77.4M 2.53% 16

Other funds holding TMO

Route One Investment Company's TMO Position: Q2 2026 in Review

Route One Investment Company increased its Thermo Fisher Scientific (TMO) stake by 8.4% in Q2 2026, buying an estimated $10.4M and bringing the position to 280,400 shares worth $141M. The position accounts for 5.65% of the portfolio, ranked #9.

Route One Investment Company first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $153M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Route One Investment Company held 280,400 shares of Thermo Fisher Scientific worth $141M as of Q2 2026.
  • Route One Investment Company bought 21,700 Thermo Fisher Scientific shares in Q2 2026, an estimated $10.4M.
  • Thermo Fisher Scientific made up 5.65% of Route One Investment Company's portfolio in Q2 2026, its #9 holding.
  • Route One Investment Company first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Route One Investment Company's Thermo Fisher Scientific position peaked at $153M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Route One Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.